N.E.W. Advisory Services LLC Gilead Sciences, Inc. Transaction History
N.E.W. Advisory Services LLC
- $1.25 Billion
- Q1 2025
A detailed history of N.E.W. Advisory Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, N.E.W. Advisory Services LLC holds 10,364 shares of GILD stock, worth $1.24 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,364
Previous 10,370
0.06%
Holding current value
$1.24 Million
Previous $957,000
21.32%
% of portfolio
0.09%
Previous 0.09%
Shares
16 transactions
Others Institutions Holding GILD
# of Institutions
2,320Shares Held
1.02BCall Options Held
11.8MPut Options Held
9.11M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.1 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.56 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.5 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...